| Global impact of the first year of COVID-19 vaccination: a mathematical modelling study OJ Watson, G Barnsley, J Toor, AB Hogan, P Winskill, AC Ghani The Lancet infectious diseases 22 (9), 1293-1302, 2022 | 1171 | 2022 |
| Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current World Health Organization guidelines? J Toor, R Alsallaq, JE Truscott, HC Turner, M Werkman, D Gurarie, ... Clinical Infectious Diseases 66 (suppl_4), S245-S252, 2018 | 108 | 2018 |
| Investigating the effectiveness of current and modified World Health Organization guidelines for the control of soil-transmitted helminth infections SH Farrell, LE Coffeng, JE Truscott, M Werkman, J Toor, SJ de Vlas, ... Clinical Infectious Diseases 66 (suppl_4), S253-S259, 2018 | 95 | 2018 |
| Vaccine equity in low and middle income countries: a systematic review and meta-analysis HA Ali, AM Hartner, S Echeverria-Londono, J Roth, X Li, K Abbas, ... International journal for equity in health 21 (1), 82, 2022 | 75 | 2022 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ... Elife 10, e67635, 2021 | 71 | 2021 |
| Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation J Toor, ER Adams, M Aliee, B Amoah, RM Anderson, D Ayabina, R Bailey, ... Clinical Infectious Diseases 72 (8), 1463-1466, 2021 | 69 | 2021 |
| The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni J Toor, HC Turner, JE Truscott, M Werkman, AE Phillips, R Alsallaq, ... PLoS neglected tropical diseases 12 (10), e0006717, 2018 | 50 | 2018 |
| Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies K Kura, D Ayabina, J Toor, TD Hollingsworth, RM Anderson Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (3 …, 2021 | 39 | 2021 |
| Economic evaluations of mass drug administration: the importance of economies of scale and scope HC Turner, J Toor, TD Hollingsworth, RM Anderson Clinical infectious diseases 66 (8), 1298-1303, 2018 | 38 | 2018 |
| A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis JE Truscott, D Gurarie, R Alsallaq, J Toor, N Yoon, SH Farrell, HC Turner, ... Epidemics 18, 29-37, 2017 | 35 | 2017 |
| Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis DV Ayabina, J Clark, H Bayley, PHL Lamberton, J Toor, TD Hollingsworth PLoS neglected tropical diseases 15 (11), e0009083, 2021 | 34 | 2021 |
| Dynamics of SARS-CoV-2 with waning immunity in the UK population T Crellen, L Pi, EL Davis, TM Pollington, TCD Lucas, D Ayabina, ... Philosophical transactions of the royal society b 376 (1829), 20200274, 2021 | 34 | 2021 |
| Testing for soil-transmitted helminth transmission elimination: Analysing the impact of the sensitivity of different diagnostic tools M Werkman, JE Wright, JE Truscott, AV Easton, RG Oliveira, J Toor, ... PLoS neglected tropical diseases 12 (1), e0006114, 2018 | 33 | 2018 |
| Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required? J Toor, D Rollinson, HC Turner, A Gouvras, CH King, GF Medley, ... The Journal of infectious diseases 221 (Supplement_5), S525-S530, 2020 | 32 | 2020 |
| Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination K Kura, JE Truscott, J Toor, RM Anderson PLOS neglected tropical diseases 13 (6), e0007349, 2019 | 31 | 2019 |
| The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination? K Kura, RJ Hardwick, JE Truscott, J Toor, TD Hollingsworth, RM Anderson Parasites & Vectors 13, 1-10, 2020 | 25 | 2020 |
| Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs HC Turner, MD French, A Montresor, CH King, D Rollinson, J Toor Wellcome Open Research 5, 2020 | 24 | 2020 |
| SCHISTOX: an individual based model for the epidemiology and control of schistosomiasis M Graham, D Ayabina, TCD Lucas, BS Collyer, GF Medley, ... Infectious Disease Modelling 6, 438-447, 2021 | 21 | 2021 |
| Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission J Toor, JE Truscott, M Werkman, HC Turner, AE Phillips, CH King, ... Parasites & vectors 12, 1-7, 2019 | 21 | 2019 |
| How can the public health impact of vaccination be estimated? S Echeverria-Londono, X Li, J Toor, MJ de Villiers, S Nayagam, TB Hallett, ... BMC Public Health 21, 1-12, 2021 | 20 | 2021 |
